RASSF1 and hepatocellular carcinoma: In our meta-analysis, in which we enrolled 44 articles and 9354 cases, RASSF1A promoter hypermethylation showed significant associations with HCC risk within tissues and peripheral blood samples, suggesting that it represents an early event in liver carcinogenesis.